Dr. Apurba Bhatacharya, Professor
Undergraduate Work: B.S. Chemistry, Calcutta University, India: 1974
Graduate Work: M.S. Chemistry, Indian Institute of Technology. Kanpur, India: 1976
Doctoral Work: Ph.D. Organic Chemistry, University of Texas at Austin: 1982 in asymmetric induction in carbon-carbon bond forming reactions. Kinetic resolutions. Chiral Diels Alder reaction. Asymmetric synthesis of natural product.
Current Research: Green chemistry. Designing environmentally benign/waste-free chemistry with special emphasis towards current industrial synthesis and processes utilizing homogeneous and heterogeneous catalyst systems. Asymmetric synthesis. Chiral Phase Transfer Catalysis.
More about research interests
Past Research: Industrial experience includes Merck (7.5 yrs), Hoechst (7.5 yrs), and Bristol Myers Squibb (2 yrs.). Developed the synthesis of Propecia™ (hair growth drug) / Proscar™ for BPH (benign prostatic hypertrophy), Chiral Robinson Annulation, Synthesis of S-ibuprofen, D-p-hydroxyphenyl glycine, Cromolyn sodium, Alkyl indanones, Quinazolinones, Amphoteric copolymer, and MRI imaging agents. As the Sr. Vice President in the world-wide Active Pharmaceutical Ingredient (API) Business in Dr Reddy’s Laboratories R&D across Asia, Europe and USA, provided leadership and strategic direction for the global R&D ensuring effective and innovative Generic drug development.
Hobbies: Watching Football (Especially DALLAS COWBOYS)
Ph.D. Organic Chemistry, University of Texas at Austin: 1982
M.S. Chemistry, I. I. T.. Kanpur, India: 1976
B.S. Chemistry, Calcutta University, India: 1974
2015-Present Professor, Texas A&M Kingsville
2008-2015 Associate Professor, Texas A&M Kingsville
2007- 2008 Senior Vice President. Dr. Reddy’s Laboratories, India.
2006-2007 Vice President, Head of Global Research & Development; Dr. Reddy’s Laboratories, India.
2004-2006 Tenured, Associate Professor
1999-2004 Assistant Professor, Texas A&M University, Kingsville.
1997-1999 Group Leader, Bristol Myers Squibb, Central Process Research
1995-1997 Lead Chemist; Innovator Group, Hoechst.
1994-1995 Staff Chemist, Hoechst-Celanese.
1990-1994 Senior Research Chemist, Hoechst-Celanese.
1988-1990 Research Fellow, Process Research and Development, Merck & Co., Inc.
1983-1988 Senior Research Chemist, Process Research and Development, Merck & Co., Inc.
A. Advisory Board for the Clinton Foundation HIV/AIDS Initiative (CHAI)
B. Member of the National Academies’ Chemical Sciences Roundtable (CSR). This is a committee of advisors that reports its recommendation of the directions of US Science to the US Congress and the President.
C. Member of the U.S. National Academies Committee on Promoting Safe and secure chemical Management in Developing countries. At the request of the US Department of State, the committee will provide guidance on a baseline of practices.to promote safety and security in the chemical industry in the developing nations.
D. American Chemical Society Green Chemistry Institute (ACS GCI) Pharmaceutical Roundtable. The mission of the roundtable is to catalyze the implementation of Green Chemistry and Green Engineering in the pharmaceutical Development.
E. Resident Consultant
1. Daiichi Sankyo Ranbaxy Laboratories.
2. Dr Reddy’s Laboratories. Hyderabad, India.
3. Pfizer-Zoetis (Animal Health) Pharmaceutical
4. Sun Pharma Delhi, India
5. Vitae Pharmaceutical Inc. Delaware, USA.
F. Editorial Board: Open Journal of Medicinal Chemistry [http://www.scirp.org/journal/ojmc/]
G. Editorial Board: Modern Research in Catalyst (MRC) [www.scirp.org/journal/MRC]
H. Editorial Board: Open Journal of Synthesis Theory and Applications [http://www.scirp.org/journal/ojsta/]
I. Editorial Board: Infinity Press: Communications in Applied Sciences
J. Editorial Board: International Journal of Bioorganic Chemistry & Molecular Biology (IJBCMB) [www.scidoc.org]
K. Editorial Board: Journal of Organic and Biomolecular Simulations. [http://thescipub.com/]
L. Editorial Board: Pharmacy Practice & Health Care. http://www.kenkyuonline.org/editorialboard.php?journal=52&title=Pharmacy-Practice-&-Health-Care
M. Member: Panel of Drug Evaluators for Current Drugs (CD). Responsible for the evaluation of drugs, which are being launched worldwide under FDA guidelines.
N. Honorary Visiting Professor at Institute of Life Sciences (ILS) Hyderabad, India.
O. Bill & Melinda Gates Foundation
P. Scientific Process Advisor:
3. PHARM-ECO A Johnson Matthey Company
4. Texas Bio Technology.
5. Bristol Myers Squibb Pharmaceutical Co.
6. Boehringer-Ingelheim Pharmaceutical.
7. Johnson & Johnson Pharmaceutical Research & Development.
9. National Advisory Committee, Osmania University, India.
10. Bill & Melinda Gates Foundation.
11. “Pharmaceutical Expert witness” in the areas of “Drug Development”
Open Journal of Medicinal Chemistry [http://www.scirp.org/journal/ojmc/]
Modern Research in Catalyst (MRC) [www.scirp.org/journal/MRC]
Open Journal of Synthesis Theory and Applications [http://www.scirp.org/journal/ojsta/]
Department of Chemistry
Nierman Hall, N205
MSC 161 Texas A&M University-Kingsville
Kingsville, Texas 78363-8202
This page was last updated on: September 29, 2015